Corifollitropin Alfa Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029)
The global corifollitropin alfa market is anticipated to grow at a significant CAGR during the forecast period. Corifollitropin alfa is a hybrid follicle stimulating hormone (FSH) molecule, which is utilized to treat infertility. The molecule when infused results in the development of a high number of metaphase II oocytes in women. The primary factor that contributes to the growth of the market is the high incidence of infertility in young population owing to several underlying causes such as polycystic ovary syndrome (PCOS) or the occurrence of blockage in the fallopian tube. As per the World Health Organization (WHO), infertility affects millions of people of reproductive age all over the globe and has an impact on their families and communities. Estimates suggest that between 48 million couples and 186 million individuals live with infertility all over the globe - as per the estimates of September 2020.
Further, a substantial growth in the number of fertility
clinics, rising awareness about infertility treating hormones among the global
population, coupled with the technological advancements in the healthcare
sector are also likely to propel the market growth. However, high cost of
infertility treatments may hinder the market growth. The improvement in corifollitropin
alfa efficacy for in vitro fertilization will further boost the market growth.
To Request a Sample of our Report on Corifollitropin
Alfa Market: https://www.omrglobal.com/request-sample/corifollitropin-alfa-market
Market Coverage
·
The market number available for – 2021-2029
·
Base year- 2021
·
Forecast period- 2023-2029
Segment Covered-
·
By Application
·
By Deployment Model
·
By End-User
Regions covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape: Merck & Co., Inc.,
and Schering-Plough Corp., among others.
Corifollitropin Alfa Market Report by Segment
By Type
·
Industrial Grade
·
Pharmaceutical Grade
By End-User
·
Hospitals
·
Laboratories
A
full Report of Corifollitropin Alfa Market is Available @ https://www.omrglobal.com/industry-reports/corifollitropin-alfa-market
Corifollitropin
Alfa Market Report by Region
· United
States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest
of Europe
Asia-Pacific
· India
· China
· Japan
· South
Korea
· Rest
of APAC
Rest of the World
•
Latin America
•
Middle East and Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data,
Request for Report Customization @ https://www.omrglobal.com/report-customization/corifollitropin-alfa-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment